Experts say the findings highlight a major gap in obesity care: While GLP-1s can help people lose substantial amounts of weight, there are few proven strategies to lock in those improvements once treatment ends
Frias JP, Davies MJ, Rosenstock J, Perez Manghi FC, Fernandez Lando L, Bergman BK, Liu B, Cui X, Brown K, Investigators S-
While people on GLP-1s for diabetes may need to be on the medicine for life, Jasik says there's a desire from individuals taking the drug for weight loss to stop
Mukhopadhyay, B
Tirzepatide doesnt directly damage the kidneys, but severe nausea, vomiting, or diarrhoea (more common when starting Mounjaro or increasing the dose) can lead to dehydration, which puts strain on the kidneys
Education, thorough testing, and consistent independent oversight constitute fundamental strategies for anti-doping compliance and responsible participation in sport